CBP and p300: HATs for different occasions
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 68 (6) , 1145-1155
- https://doi.org/10.1016/j.bcp.2004.03.045
Abstract
No abstract availableKeywords
Funding Information
- Koninklijke Nederlandse Akademie van Wetenschappen
This publication has 143 references indexed in Scilit:
- Nucleosome Binding by the Bromodomain and PHD Finger of the Transcriptional Cofactor p300Journal of Molecular Biology, 2004
- Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instabilityOncogene, 2004
- Concomitant Increase of Histone Acetyltransferase Activity and Degradation of p300 during Retinoic Acid-induced Differentiation of F9 CellsPublished by Elsevier ,2003
- A Novel Mutation Lacking the Bromodomain of the Transcriptional Coactivator p300 in the SiHa Cervical Carcinoma Cell LineBiochemical and Biophysical Research Communications, 2001
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- The language of covalent histone modificationsNature, 2000
- Phosphorylation by p44 MAP Kinase/ERK1 Stimulates CBP Histone Acetyl Transferase Activity in VitroBiochemical and Biophysical Research Communications, 1999
- The Transcriptional Coactivators p300 and CBP Are Histone AcetyltransferasesPublished by Elsevier ,1996
- MAP Kinase-Dependent Transcriptional Coactivation by Elk-1 and Its Cofactor CBPBiochemical and Biophysical Research Communications, 1996
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971